United States Undescended Testicle Market Size & Forecast:
- United States Undescended Testicle Market Size 2025: USD 845.2 Million
- United States Undescended Testicle Market Size 2033: USD 1528.3 Million
- United States Undescended Testicle Market CAGR: 7.73%
- United States Undescended Testicle Market Segments:By Treatment Type (Hormonal Therapy, Surgical Treatment – Orchiopexy), By End User (Hospitals, Pediatric Clinics, Specialty Surgical Centers).

To learn more about this report, Download Free Sample Report
United States Undescended Testicle Market Summary:
The United States Undescended Testicle Market size is estimated at USD 845.2 Million in 2025 and is anticipated to reach USD 1528.3 Million by 2033, growing at a CAGR of 7.73% from 2026 to 2033. People now understand the condition better, which enables doctors to identify it earlier. Medical professionals continue to develop their skills, which has resulted in growth for the United States' undescended testicle market. The medical field has started to show better treatment results because doctors now recognise the importance of performing orchiopexy surgery at the earliest possible time. Healthcare providers are developing two areas, which include less invasive procedures and improved methods for patient care after surgery. The market continues to expand because government programmes and better access to specialised medical facilities support the growth, whereas research efforts enhance knowledge and treatment methods for this medical condition.
Key Market Trends & Insights:
- The parents together with the healthcare providers now know that early detection requires detection during its initial stage. The condition gets diagnosed earlier through neonatal screenings and paediatric check-ups, which lead to better treatment outcomes.
- People now prefer surgical methods that use less invasive techniques such as laparoscopic orchiopexy. These methods help patients recover faster while they experience fewer complications and better overall comfort.
- Medical guidelines now recommend doctors to perform surgical procedures during a patient's first year after birth. The current trend for early medical procedures helps decrease infertility and testicular cancer risks which will last throughout a person's life.
- The development of new surgical instruments and methods yields better surgical results because they give doctors more accurate control. Paediatric urology centres provide advanced medical services through their specialised facilities.
- The United States healthcare system functions through its established medical centres and its system of health insurance. This system guarantees that patients can access diagnosis, treatment and post-treatment medical services.
- Researchers are studying the genetic and hormonal and environmental factors which contribute to the condition. These research efforts will enhance treatment methods while creating opportunities for future non-surgical treatment options.
- Healthcare providers have started to track patient progress after their surgical procedures to evaluate their reproductive capabilities and sex hormone levels. This approach for ongoing patient treatment development creates more effective methods for delivering medical care.
United States Undescended Testicle Market Segmentation
By Treatment Type
- Hormonal Therapy: Hormonal therapy is occasionally applied to treat mild cases of testicular descent problems in infants who are still too young for surgical intervention. The treatment provides an alternative to surgery because it does not require any invasive procedures. The treatment maintains its value because it can be used in particular medical situations which require surgical procedures to be postponed.
- Surgical Treatment Orchiopexy: Orchiopexy is the most widely recommended and effective treatment for undescended testicles. The procedure which involves testicle relocation to the scrotum occurs during the early childhood stage. The procedure achieves high success rates while minimising future health complications and receiving support from established clinical guidelines that exist throughout the United States.

To learn more about this report, Download Free Sample Report
By End User
- Hospitals: The advanced infrastructure and skilled surgeons at hospitals create a major hospital segment because of their capabilities. Hospitals use their advanced medical systems to treat difficult medical situations while offering complete care during and after surgical procedures. The combination of advanced diagnostic equipment and emergency medical services enables hospitals to function as dependable medical facilities which parents can trust for safe medical treatments.
- Pediatric Clinics: Pediatric clinics function as essential medical facilities which provide diagnostic services and continuous patient assessment throughout their development. Parents typically first visit these medical facilities, which help them receive immediate medical treatment through direct patient referrals. The medical facility establishes trust with families through its safe space for children and its expert medical services which promote early detection of health issues.
- Specialty Surgical Centers: Specialty surgical centres have become more popular because they provide surgical services which focus on delivering quick and effective treatment. Their customers experience shorter waiting periods because they implement efficient operational methods which deliver individualised service. Those which specialise in minimally invasive methods have emerged as the top choice for patients who need basic orchidopexy operations across the United States.
Country Insights
The United States undescended testicle market demonstrates efficient healthcare operations which depend on modern medical technology and extensive clinical expertise. The condition gets detected through early screening programmes combined with standard paediatric checkups which enable doctors to deliver necessary treatment at the optimal moment. The country benefits from a high availability of skilled paediatric urologists and established treatment protocols, especially for orchiopexy procedures, which remain the standard of care.
The combination of favourable insurance coverage and government healthcare programmes enhances accessibility to both diagnosis and treatment. The growing parental awareness about child health combined with educational efforts about child health promotes parents to take their children for medical checkups. The U.S. research institutions and hospitals conduct studies about long-term medical outcomes to enhance ongoing patient care quality. The market development occurs through innovative solutions which increase access to healthcare while delivering treatment that prioritises patient needs.
Recent Development News
In February 2026, Early Surgery Guidelines Gain Stronger Push in US Pediatric Care: Growing emphasis on performing orchiopexy within the first year is shaping treatment demand. Experts highlight improved fertility outcomes and reduced cancer risks with early intervention.
In May 2024, Minimally Invasive Surgery Trends Rise Across the U.S.: Laparoscopic orchiopexy is gaining popularity due to faster recovery and fewer complications. Hospitals are adopting advanced surgical technologies to improve outcomes.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 845.2 Million |
|
Market size value in 2026 |
USD 907.5 Million |
|
Revenue forecast in 2033 |
USD 1528.3 Million |
|
Growth rate |
CAGR of 7.73% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 – 2024 |
|
Forecast period |
2026 – 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Country scope |
United States |
|
Key company profiled |
Pfizer Inc., Johnson & Johnson, Medtronic PLC, B. Braun Melsungen AG, Boston Scientific Corporation, Abbott Laboratories, Baxter International Inc., Cook Medical Inc., Olympus Corporation, Stryker Corporation, Smith & Nephew PLC, Zimmer Biomet Holdings Inc., Teleflex Incorporated, Integra LifeSciences Holdings Corp., Karl Storz SE & Co. KG. |
|
Customization scope |
Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs. |
|
Report Segmentation |
By Treatment Type (Hormonal Therapy, Surgical Treatment – Orchiopexy), By End User (Hospitals, Pediatric Clinics, Specialty Surgical Centers). |
Key United States Undescended Testicle Company Insights
The United States undescended testicle market exists because established healthcare providers and specialised pediatric hospitals and medical device companies that develop surgical solutions all work together to support this market. The major industry players concentrate their efforts on developing advanced surgical instruments which enable doctors to use less invasive procedures that result in better results for patients. The companies invest their resources into research projects which will help them gain insights about how effective treatments work and what effects those treatments create on patients in the future.
The organization collaborates with hospitals and clinics to develop a strong network which improves its ability to deliver medical services and increase the quality of its patient care. The competitive environment exists because organisations create novel solutions, medical professionals possess specialised knowledge, and all parties work to enhance pediatric urology services.
Company List
- Pfizer Inc
- Johnson & Johnson
- Medtronic PLC
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Abbott Laboratories
- Baxter International Inc
- Cook Medical Inc
- Olympus Corporation
- Stryker Corporation
- Smith & Nephew PLC
- Zimmer Biomet Holdings Inc.
- Teleflex Incorporated
- Integra LifeSciences Holdings Corp
- Karl Storz SE & Co. KG.
United States Undescended Testicle Market Report Segmentation
By Treatment Type:
- Hormonal Therapy
- Surgical Treatment - Orchiopexy
By End User
- Hospitals
- Pediatric Clinics
- Specialty Surgical Centers
Frequently Asked Questions
Find quick answers to common questions.
The approximate United States Undescended Testicle Market size for the market will be USD 1528.3 Million in 2033.
The key segments of the United States Undescended Testicle Market are By Treatment Type (Hormonal Therapy, Surgical Treatment – Orchiopexy), By End User (Hospitals, Pediatric Clinics, Specialty Surgical Centers).
Major players in the United States Undescended Testicle Market are Pfizer Inc., Johnson & Johnson, Medtronic PLC, B. Braun Melsungen AG, Boston Scientific Corporation, Abbott Laboratories, Baxter International Inc., Cook Medical Inc., Olympus Corporation, Stryker Corporation, Smith & Nephew PLC, Zimmer Biomet Holdings Inc., Teleflex Incorporated, Integra LifeSciences Holdings Corp., Karl Storz SE & Co. KG.
The current market size of the United States Undescended Testicle Market is USD 845.2 Million in 2025.
The United States Undescended Testicle Market CAGR is 7.73%.
- Pfizer Inc
- Johnson & Johnson
- Medtronic PLC
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Abbott Laboratories
- Baxter International Inc
- Cook Medical Inc
- Olympus Corporation
- Stryker Corporation
- Smith & Nephew PLC
- Zimmer Biomet Holdings Inc.
- Teleflex Incorporated
- Integra LifeSciences Holdings Corp
- Karl Storz SE & Co. KG.
Recently Published Reports
-
Dec 2025
Biosimilars Market
Biosimilars Market By Product Type (Monoclonal Antibodies, Recombinant Hormones, Erythropoietin, G-CSF, Others), By Indication (Oncology, Autoimmune Diseases, Blood Disorders, Diabetes, Others), By Manufacturing Type (In-House Manufacturing, Contract Manufacturing), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2033
-
Dec 2025
Gastrointestinal Endoscopy Market
Gastrointestinal Endoscopy Market By Type (Rigid Gastrointestinal Endoscope, Flexible Gastrointestinal Endoscopes, Disposable Gastrointestinal Endoscope), By Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Flexible Sigmoidoscopy, Others), By Application (Diagnosis, Treatment), By End-Users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, Others), By Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2033
-
Jan 2026
Rare Inherited Metabolic Disorder Drug Market
Rare Inherited Metabolic Disorder Drug Market By Drug Class (Enzyme Replacement Drugs, Gene Therapy Drugs, Substrate Reduction Drugs, Small Module Drugs, Protein Drugs), By Route of Administration(Parenteral, Oral, Intrathecal), By Clinical Development (Marketed Drugs, Late Stage Clinical Phase III, Early Stage Clinical Phase I-II, Preclinical Candidates), By Indication (Lysosomal Storage Disorders, Urea Cycle Disorders, Amino Acid Metabolic Disorders, organic Acidemias, Peroximal Disorders), By Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2033
-
Jan 2026
Pharmaceutical Cleanroom Technology Market
Pharmaceutical Cleanroom Technology Market By Product (Equipment, Consumables, Services); By Cleanroom Type (Standard Cleanrooms, Modular Cleanrooms); By End Use (Pharmaceutical Companies, Biotechnology Companies), By Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2033